Spero Therapeutics
Clinical trials sponsored by Spero Therapeutics, explained in plain language.
-
New pill fights tough lung infection in trial
Disease control CompletedThis study tested whether a new oral drug called SPR720 could help people with a chronic lung infection called MAC. It compared the drug to a placebo in 25 participants over 56 days to see if it reduced the amount of bacteria in their lungs and improved their symptoms. The main g…
Phase: PHASE2 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 06:20 UTC
-
Pill could replace IV drips for serious infections
Disease control CompletedThis large, completed Phase 3 study compared a new oral antibiotic pill to a standard intravenous (IV) antibiotic for hospitalized adults with serious kidney or urinary tract infections. The goal was to see if the pill worked just as well to cure the infection and clear the bacte…
Phase: PHASE3 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC